Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00542256 · ClinicalTrials.gov registry record · NA

tDCS and Physical Therapy in Stroke

A NA study of Cerebrovascular Accident, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT00542256 is a NA study of Cerebrovascular Accident that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 85 participants, below the 515-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00542256, a NA study of Cerebrovascular Accident, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a painless and noninvasive procedure called transcranial direct current stimulation (tDCS) combined with a method of physical therapy called constraint-induced movement therapy improves motor function in patients with chronic stroke. Research in healthy subjects has shown that when tDCS is combined with motor learning tasks, there is an increase in learning as compared to motor learning tasks only. The tDCS procedure sessions will be compared to sham (fake) procedure sessions, which is also called placebo stimulation. This study is double blind, which means neither the subjects nor researchers analyzing motor function will know if participants are receiving real tDCS stimulation or placebo. Only the person performing the procedure will know which one participants are receiving. Only by comparing the tDCS procedure to a sham (placebo) procedure can we understand if the tDCS actually improves motor function. We hypothesize that tDCS will enhance the effects of constraint-induced movement therapy on motor recovery in chronic stroke patients.

Conditions Studied

Interventions

  • DEVICE Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy
  • DEVICE Sham transcranial Direct Current Stimulation / Constraint Induced Movement Therapy

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2007-09
Est. Completion 2014-11-10
Phase NA

What the Registry Record Tells You About NCT00542256

The ClinicalTrials.gov registry entry for NCT00542256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 515-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (83% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cerebrovascular Accident appearing as the primary indexed condition, and to 2 interventions - of which Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy is the first listed.

NCT00542256 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00542256 about?

NCT00542256 is a clinical study titled "tDCS and Physical Therapy in Stroke". The purpose of this study is to determine whether a painless and noninvasive procedure called transcranial direct current stimulation (tDCS) combined with a method of physical therapy called constraint-induced movement therapy improves motor function in patients with chronic stroke. Research in heal...

What is the current status of trial NCT00542256?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2007-09. Estimated completion is 2014-11-10.

What conditions does trial NCT00542256 study?

This clinical trial studies the following conditions: Cerebrovascular Accident.

What interventions are being tested in trial NCT00542256?

The interventions under investigation include: Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy (DEVICE), Sham transcranial Direct Current Stimulation / Constraint Induced Movement Therapy (DEVICE).

Who is sponsoring clinical trial NCT00542256?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00542256 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebrovascular Accident

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.